BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 35498820)

  • 1. Identification and characterization of
    Al-Shakliah NS; Attwa MW; Kadi AA; AlRabiah H
    RSC Adv; 2020 Apr; 10(28):16231-16244. PubMed ID: 35498820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of in vivo, in vitro and reactive metabolites of vandetanib using LC-ESI-MS/MS.
    Attwa MW; Kadi AA; Darwish HW; Amer SM; Al-Shakliah NS
    Chem Cent J; 2018 Sep; 12(1):99. PubMed ID: 30251155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Iminium Intermediates Generation in the Metabolism of Tepotinib Using LC-MS/MS: In Silico and Practical Approaches to Bioactivation Pathway Elucidation.
    Abdelhameed AS; Attwa MW; Kadi AA
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33126762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ion Trap LC/MS reveals the generation of reactive intermediates in acalabrutinib metabolism: phase I metabolic profiling and bioactivation pathways elucidation.
    Alsibaee AM; Aljohar HI; Attwa MW; Abdelhameed AS; Kadi AA
    RSC Adv; 2024 May; 14(23):16170-16193. PubMed ID: 38769961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Stable and Reactive Metabolites of the Anticancer Drug, Ensartinib, in Human Liver Microsomes Using LC-MS/MS: An in silico and Practical Bioactivation Approach.
    Abdelhameed AS; Attwa MW; Kadi AA
    Drug Des Devel Ther; 2020; 14():5259-5273. PubMed ID: 33299299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of in vivo metabolites in rat urine following an oral dose of masitinib by liquid chromatography tandem mass spectrometry.
    Kadi AA; Amer SM; Darwish HW; Attwa MW
    Chem Cent J; 2018 May; 12(1):61. PubMed ID: 29766296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive intermediates in naquotinib metabolism identified by liquid chromatography-tandem mass spectrometry: phase I metabolic profiling.
    Attwa MW; Kadi AA; AlRabiah H; Darwish HW
    RSC Adv; 2019 Mar; 9(18):10211-10225. PubMed ID: 35520926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species-specific Bioactivation of Morpholines as a Causative of Drug Induced Liver Injury Observed in Monkeys.
    Gunduz M; Argikar UA; Cirello AL; Brown AP; Bonazzi S; Walles M
    Drug Metab Bioanal Lett; 2023 Dec; ():. PubMed ID: 38047363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid chromatography-tandem mass spectrometry metabolic profiling of nazartinib reveals the formation of unexpected reactive metabolites.
    Abdelhameed AS; Attwa MW; Kadi AA
    R Soc Open Sci; 2019 Aug; 6(8):190852. PubMed ID: 31598253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of the rat in-vivo and in-vitro metabolites of tazemetostat using LC-QTOF-MS.
    Rajput N; Jadav T; Sengupta P
    Food Chem Toxicol; 2024 Jun; 190():114785. PubMed ID: 38849047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galeon: A Biologically Active Molecule with In Silico Metabolite Prediction, In Vitro Metabolic Profiling in Rat Liver Microsomes, and In Silico Binding Mechanisms with CYP450 Isoforms.
    Rahman AFMM; Yin W; Kadi AA; Jahng Y
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33322201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of alcohol ethoxylates (AEs) in rat, hamster, and human hepatocytes and liver S9: a pilot study for metabolic stability, metabolic pathway, and metabolites identification in vitro and in silico.
    Shi Q; Moors S; Dawick J; Kavanagh L; Neely T; Tian Y; Dreeßen B; Carrillo JC; Hein H; Boogaard PJ
    Arch Toxicol; 2024 Jun; ():. PubMed ID: 38844554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covalent Modification of Proteins by Osthole Reactive Metabolites using Proteomic Approaches.
    Zhuo Y; Chen H; Liu C; Zhang Y; Fang J; Li M; Wang Z; Jiang Q; Yu L; Pan H; Wang Q
    Curr Drug Metab; 2023; 24(8):611-620. PubMed ID: 37519003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of highly potent synthetic opioid nitazene analogs: N-ethyl-N-(1-glucuronyloxyethyl) metabolite formation and degradation to N-desethyl metabolites during enzymatic hydrolysis.
    Kanamori T; Okada Y; Segawa H; Yamamuro T; Kuwayama K; Tsujikawa K; Iwata YT
    Drug Test Anal; 2024 Apr; ():. PubMed ID: 38679851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of cytochrome P450-mediated bioactivation using machine learning models and in vitro validation.
    Hu XM; Hou YY; Teng XR; Liu Y; Li Y; Li W; Li Y; Ai CZ
    Arch Toxicol; 2024 May; 98(5):1457-1467. PubMed ID: 38492097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective Stability Indicating Liquid Chromatographic Method Based on Quality by Design Framework and In Silico Toxicity Assessment for Infigratinib and Its Degradation Products.
    Ali AM; Alanazi MM; Attwa MW; Darwish HW
    Molecules; 2023 Nov; 28(22):. PubMed ID: 38005198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustainable chromatographic quantitation of multi-antihypertensive medications: application on diverse combinations containing hydrochlorothiazide along with LC-MS/MS profiling of potential impurities: greenness and whiteness evaluation.
    Marzouk HM; El-Hanboushy S; Obaydo RH; Fayez YM; Abdelkawy M; Lotfy HM
    BMC Chem; 2023 Aug; 17(1):101. PubMed ID: 37598182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of bergapten on the pharmacokinetics of macitentan in rats both
    Xu J; Zhou Q; Hou P; Wang Y; Geng P; Lu Z; Zhou Y; Dai D; Wang S
    Front Pharmacol; 2023; 14():1204649. PubMed ID: 37492094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A distinction between Fritillaria Cirrhosa Bulbus and Fritillaria Pallidiflora Bulbus via LC-MS/MS in conjunction with principal component analysis and hierarchical cluster analysis.
    Liu C; Liu S; Tse WM; Tse KWG; Erbu A; Xiong H; Lanzi G; Liu Y; Ye B
    Sci Rep; 2023 Feb; 13(1):2735. PubMed ID: 36792675
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.